{
  "ticker": "LLY",
  "timestamp": "2025-12-01T08:51:33.410716",
  "analysis_date": "2025-04-21",
  "historical_mode": true,
  "summary": {
    "recommendations": {
      "technical": "HOLD",
      "news": "BUY",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "valid_recommendations": {
      "technical": "HOLD",
      "news": "BUY",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "confidence_levels": {
      "technical": "Low",
      "news": "High",
      "fundamental": "Low",
      "macro": "Low"
    },
    "bull_signal_count": 36,
    "bear_signal_count": 8,
    "bull_rec_count": 1,
    "bear_rec_count": 0,
    "hold_rec_count": 3,
    "undetermined_count": 0,
    "analyst_count": 4,
    "valid_analyst_count": 4,
    "net_sentiment": "BULLISH"
  },
  "analyst_summaries": {
    "technical": "TECHNICAL: Uptrend confirmed, RSI 14 \u2192 HOLD (Low)",
    "news": "NEWS: Bullish sentiment (120 articles) \u2192 BUY (High)",
    "fundamental": "FUNDAMENTAL: Mixed fundamentals \u2192 HOLD (Low)",
    "macro": "MACRO: Mixed macro \u2192 HOLD (Low)"
  },
  "full_analyst_reports": {
    "technical": "[TECHNICAL] *** HISTORICAL MODE: Analyzing as of 2025-04-21 ***\n\n======================================================================\nTECHNICAL ANALYSIS: LLY\nAnalysis Period: 7 days\n*** HISTORICAL MODE: As of 2025-04-21 ***\nTimestamp: 2025-12-01 08:49:57\n======================================================================\n\n[TECHNICAL] Fetching 7-day price data for LLY...\n[TECHNICAL] \u2713 Historical: 51 days ending 2025-04-21\n[TECHNICAL]   Date range: 2025-02-06 to 2025-04-21\n[TECHNICAL] \u2713 Retrieved 51 days of data\n[TECHNICAL] Calculating technical indicators...\n[TECHNICAL] \u2713 Indicators calculated\n[TECHNICAL] Identifying support/resistance levels...\n[TECHNICAL] \u2713 Support: $673.24, Resistance: $869.94\n[TECHNICAL] Formatting technical summary...\n[TECHNICAL] Generating analysis with gpt-4o-mini...\n[TECHNICAL] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[TECHNICAL] Creating fallback analysis...\n\n[TECHNICAL] \u2713 Analysis complete in 18.82s\n======================================================================\n\n## Technical Analysis\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-21 \u26a0\ufe0f**\nAll data below is historical, ending on 2025-04-21.\nDo NOT reference any price movements or events after this date.\n\n# Technical Analysis Data for LLY\n\n**Analysis Period:** 7 days (Data: 51 days available)\n**Date:** 2025-04-21\n\n## Price Action\n- **Current Price:** $813.36\n- **Period Change:** +13.47%\n- **Day's Range:** $802.41 - $839.11\n- **Volume:** 3,326,600\n- **Volume Assessment:** Normal levels\n\n## Momentum Indicators\n- **RSI(14):** 49.0 \u2192 Neutral zone\n- **MACD:** -16.115 | Signal: -24.663 | Histogram: 8.547\n  \u2192 Bullish momentum \u2713\n- **Stochastic:** %K=77.9, %D=68.6\n\n## Moving Average Analysis\n- **SMA_5:** $776.44 (Above \u2713)\n- **EMA_10:** $773.70 (Above \u2713)\n- **SMA_20:** $781.84 (Above \u2713)\n- **SMA_50:** $829.71 (Below \u26a0\ufe0f)\n\n**Trend:** Uptrend (price above most MAs)\n\n## Volatility & Range\n- **Bollinger Bands:** $685.96 < $813.36 < $877.72\n  \u2192 Middle range (66% position)\n  \u2192 Wide bands (24.5%) - High volatility\n- **ATR:** $45.48 (5.59% of price)\n  \u2192 High volatility (wider stops needed) \u26a0\ufe0f\n\n## Support & Resistance\n- **Key Resistance:** $869.94\n- **Secondary Resistance:** $861.94\n- **Key Support:** $673.24\n- **Secondary Support:** $685.08\n\n- **Distance to Resistance:** +7.0%\n- **Distance to Support:** +20.8%\n\n## Potential Trade Setup\n- **Setup Type:** LONG\n- **Entry:** $813.36\n- **Stop Loss:** $745.14 (Risk: $68.23)\n- **Target:** $869.94 (Reward: $56.58)\n- **Risk/Reward Ratio:** 0.83:1\n  \u2192 Poor risk/reward \u26a0\ufe0f\n\n\n---\n\n## Automated Assessment\n\n**Signals Detected:** 1 bullish, 0 bearish\n**Reasoning:** Mixed or weak signals\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "news": "[NEWS] *** HISTORICAL MODE: Analyzing as of 2025-04-21 ***\n\n======================================================================\nNEWS & SENTIMENT ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-04-21 ***\nPeriod: Last 7 days | Sources: ['yahoo', 'finnhub']\nTimestamp: 2025-12-01 08:50:18\n======================================================================\n\n[NEWS] \ud83d\udd27 Fetching Yahoo Finance news...\n[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support\n[NEWS] \u2713 Yahoo Finance: 0 articles\n[NEWS] \ud83d\udd27 Fetching Finnhub news...\n[NEWS] Finnhub: Fetching news from 2025-04-14 to 2025-04-21\n[NEWS] \u2713 Finnhub: 120 articles\n[NEWS] \ud83d\udccb Enhancing 120 articles with background context\n[NEWS] \u26a0\ufe0f Date 2025-04-21 is past LLM knowledge cutoff (2024-01-01)\n[NEWS] \u26a0\ufe0f Skipping LLM context to prevent hallucination\n[NEWS] Analyzing with gpt-4o-mini...\n[NEWS] \u2713 Analysis complete (2126 chars)\n\n[NEWS] \u2713 Analysis complete in 28.41s\n======================================================================\n\n# News & Sentiment Analysis: LLY\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-21 \u26a0\ufe0f**\n**Analysis Period:** Last 7 Days\n**Date:** 2025-12-01 08:50\n\n======================================================================\n\n## Yahoo Finance News (7 Days before 2025-04-21)\n\nNo news found in the specified period\n(Historical mode: news before 2025-04-21)\n## Finnhub News (2025-04-14 to 2025-04-21)\n\n**Found 120 articles**\n\n1. **These Stocks Moved the Most Today: Tesla, Nvidia, Amazon, Netflix, Discover, Salesforce, UnitedHealth, and More**\n   - Source: Yahoo\n   - Published: today\n   - Tesla slides ahead of quarterly earnings scheduled for Tuesday, and Nvidia tumbles with the chip maker a victim of the U.S.-China trade war....\n\n2. **5 Reasons To Buy Eli Lilly**\n   - Source: SeekingAlpha\n   - Published: today\n\n3. **Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy According to Analysts**\n   - Source: Yahoo\n   - Published: today\n   - We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are going to take a look at whe...\n\n4. **These Stocks Are Moving the Most Today: Netflix, Tesla, Nvidia, Amazon, Discover, Salesforce, and More**\n   - Source: Yahoo\n   - Published: today\n   - Netflix shares rise following better-than-expected earnings, and Tesla slides ahead of quarterly earnings scheduled for Tuesday....\n\n5. **Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?**\n   - Source: Yahoo\n   - Published: today\n   - Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019.  Is it time to buy the di...\n\n6. **Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know**\n   - Source: Yahoo\n   - Published: today\n   - Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stoc...\n\n7. **LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study**\n   - Source: Yahoo\n   - Published: today\n   - Eli Lilly's stock surges as its investigational oral GLP-1 pill, orforglipron, achieves the primary and key secondary goals in the first late-stage st...\n\n8. **Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges**\n   - Source: Yahoo\n   - Published: today\n   - Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks....\n\n\n======================================================================\n\n## News & Sentiment Summary\nEli Lilly (LLY) has garnered significant positive attention recently due to a successful Phase III study of its oral GLP-1 pill, which has contributed to a surge in stock price. Analyst recommendations and growing interest from investors reflect a bullish sentiment towards the company, despite being overshadowed by broader market movements.\n\n## Key Headlines\n1. **LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study**\n   - **Impact Assessment:** High - Positive clinical results often lead to significant stock appreciation and investor confidence.\n   \n2. **5 Reasons To Buy Eli Lilly**\n   - **Impact Assessment:** Medium - Analyst opinions can influence buying behavior, especially if backed by solid data.\n   \n3. **Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know**\n   - **Impact Assessment:** Medium - Increased investor interest typically correlates with stock price appreciation.\n   \n4. **Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy According to Analysts**\n   - **Impact Assessment:** Medium - Recognition as a strong dividend stock can attract income-focused investors, boosting demand.\n\n## Sentiment Assessment\n- **Overall Sentiment:** Bullish\n- **Sentiment Trend:** Improving\n- **News Volume:** High\n\n## Catalysts Identified\n**Bullish Catalysts:**\n- Successful Phase III study results for the oral GLP-1 pill (orfglipron).\n- Recognition as a top dividend stock by analysts.\n- Increased media coverage and investor interest.\n\n**Bearish Catalysts:**\n- General market volatility affecting investor sentiment (though not specific to LLY).\n\n**Upcoming Events:**\n- No specific upcoming events mentioned in the news.\n\n## Trading Implications\nGiven the positive news surrounding the successful Phase III study and overall bullish sentiment, LLY appears positioned for continued upward momentum. The combination of clinical trial success, favorable analyst opinions, and strong investor interest suggests that the stock may experience further gains in the near term.\n\nRECOMMENDATION: BUY - Confidence: High\n",
    "fundamental": "[FUNDAMENTALS] *** HISTORICAL MODE: Analyzing as of 2025-04-21 ***\n\n======================================================================\nFUNDAMENTAL ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-04-21 ***\nTimestamp: 2025-12-01 08:50:49\n======================================================================\n\n[FUNDAMENTALS] Fetching comprehensive data for LLY...\n[FUNDAMENTALS] \u2713 Comprehensive data retrieved\n[FUNDAMENTALS] Calculating historical metrics for 2025-04-21...\n[FUNDAMENTALS] \u2713 Historical metrics calculated: 4\n[FUNDAMENTALS]   - Price: $813.36\n[FUNDAMENTALS]   - P/E: 89.44\n[FUNDAMENTALS]   - P/B: 46.18\n[FUNDAMENTALS]   - Current Ratio: 1.37\n[FUNDAMENTALS] Analyzing earnings history...\n[FUNDAMENTALS] Filtering earnings to before 2025-04-21\n[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)\n[FUNDAMENTALS] Fetching SEC 10-K filing data...\n[FUNDAMENTALS] Generating analysis with gpt-4o-mini...\n[FUNDAMENTALS] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[FUNDAMENTALS] \u2713 Analysis complete in 19.46s\n======================================================================\n\n## Fundamental Analysis Summary\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-21 \u26a0\ufe0f**\nMetrics marked \"N/A\" could not be calculated historically - ignore them in your analysis.\nOnly analyze metrics with actual values.\n\n# Fundamental Data for LLY\n\n## Company Information\n- **Name:** Eli Lilly and Company\n- **Sector:** Healthcare\n- **Industry:** Drug Manufacturers - General\n\n## Current Price\n- **Price:** $813.36\n- **52-Week High:** $1111.99\n- **52-Week Low:** $623.78\n\n## Valuation Metrics\n- **Market Cap:** $964.11B\n- **Enterprise Value:** $995.68B\n- **Trailing P/E:** 89.44\n- **Forward P/E:** N/A (historical - forward-looking)\n- **PEG Ratio:** N/A (historical)\n- **Price/Book:** 46.18\n- **Price/Sales:** 16.23\n- **EV/Revenue:** 16.76\n- **EV/EBITDA:** 34.66\n\n## Growth Metrics\n- **Revenue Growth:** 53.9%\n- **Earnings Growth:** 480.4%\n- **Quarterly Revenue Growth:** N/A\n- **Quarterly Earnings Growth:** N/A\n\n## Profitability\n- **Profit Margin:** 31.0%\n- **Operating Margin:** 48.3%\n- **Gross Margin:** 83.0%\n- **ROE:** 96.5%\n- **ROA:** 17.6%\n\n## Financial Health\n- **Current Ratio:** 1.37\n- **Quick Ratio:** 0.72\n- **Debt/Equity:** 178.52\n- **Total Cash:** $9.91B\n- **Total Debt:** $42.58B\n- **Free Cash Flow:** $1.40B\n\n## Analyst Opinions\n- **Recommendation:** BUY\n- **Number of Analysts:** 27\n- **Target (Mean):** $1024.00\n- **Target (High):** $1500.00\n- **Target (Low):** $770.00\n- **Implied Upside:** -4.8%\n\n## Earnings History (Last 4 Quarters)\n- Unknown: Actual $5.32 vs Est $5.07 (+5.0%) \u2713 Beat\n- Unknown: Actual $3.34 vs Est $3.54 (-5.7%) \u2717 Miss\n- Unknown: Actual $6.31 vs Est $5.59 (+12.9%) \u2713 Beat\n- Unknown: Actual $7.02 vs Est $5.89 (+19.2%) \u2713 Beat\n\n**Summary:** Beat Rate: 75%, Trend: Declining, Quality: Strong\n\n\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "macro": "[MACRO] *** HISTORICAL MODE: Analyzing as of 2025-04-21 ***\n\n======================================================================\nMACRO ECONOMIC ANALYSIS\nPeriod: 7 days | Sector: All\n*** HISTORICAL MODE: As of 2025-04-21 ***\nTimestamp: 2025-12-01 08:51:11\n======================================================================\n\n[MACRO] Starting iterative analysis...\n[MACRO] Iteration 1/10\n[MACRO] \ud83d\udd27 Executing: get_market_indicators\n[MACRO] \ud83d\udd27 Tool: get_market_indicators (days=7)\n[MACRO] \u2713 Fetched 6/6 indicators\n[MACRO] \ud83d\udd27 Executing: get_sector_performance\n[MACRO] \ud83d\udd27 Tool: get_sector_performance (days=7)\n[MACRO] \u2713 Analyzed 9/9 sectors\n[MACRO] \ud83d\udd27 Executing: get_economic_indicators\n[MACRO] \ud83d\udd27 Tool: get_economic_indicators (days=7)\n[MACRO] \u2713 Economic indicators retrieved\n[MACRO] \ud83d\udd27 Executing: get_market_breadth\n[MACRO] \ud83d\udd27 Tool: get_market_breadth (days=7)\n[MACRO] \u2713 Breadth analysis complete\n[MACRO] Iteration 2/10\n[MACRO] \u274c Error in iterative analysis: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[MACRO] \u2713 Complete in 21.83s\n======================================================================\n\n# Macro Analysis (Partial)\n*Analysis Period: 7 days*\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-21**\n*Successful Tools: 4, Failed: 0*\n\nRaw data gathered successfully:\n\nTools executed: get_market_indicators, get_sector_performance, get_economic_indicators, get_market_breadth\n\nRECOMMENDATION: NEUTRAL - Confidence: Low (Partial data)\n\n"
  },
  "bull_evidence": [
    {
      "source": "technical",
      "signal": "\u2192 Bullish momentum \u2713",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "technical",
      "signal": "[TECHNICAL] \u2713 Support: $673",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "## Momentum Indicators",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Support:** $673",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Support:** $685",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Support:** +20",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Given the positive news surrounding the successful Phase III study and overall bullish sentiment, LLY appears positioned for continued upward momentum",
      "strength": 3,
      "keywords_matched": 3
    },
    {
      "source": "news",
      "signal": "[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**5 Reasons To Buy Eli Lilly**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy According to Analysts**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Is it time to buy the di",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Eli Lilly (LLY) has garnered significant positive attention recently due to a successful Phase III study of its oral GLP-1 pill, which has contributed to a surge in stock price",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Analyst recommendations and growing interest from investors reflect a bullish sentiment towards the company, despite being overshadowed by broader market movements",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- **Impact Assessment:** High - Positive clinical results often lead to significant stock appreciation and investor confidence",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**5 Reasons To Buy Eli Lilly**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- **Impact Assessment:** Medium - Analyst opinions can influence buying behavior, especially if backed by solid data",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy According to Analysts**",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "bear_evidence": [
    {
      "source": "technical",
      "signal": "24, Resistance: $869",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Resistance:** $869",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Resistance:** $861",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Resistance:** +7",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Risk/Reward Ratio:** 0",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Poor risk/reward \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Reasoning:** Mixed or weak signals",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bearish Catalysts:**",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "key_conflicts": [
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "news",
        "technical"
      ],
      "positions": {
        "news": "BUY",
        "technical": "HOLD"
      },
      "description": "news says BUY while technical says HOLD"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "news"
      ],
      "positions": {
        "fundamental": "HOLD",
        "news": "BUY"
      },
      "description": "fundamental says HOLD while news says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "macro",
        "news"
      ],
      "positions": {
        "macro": "HOLD",
        "news": "BUY"
      },
      "description": "macro says HOLD while news says BUY"
    }
  ],
  "consensus_points": [
    {
      "type": "strong_consensus",
      "recommendation": "HOLD",
      "count": 3,
      "description": "Strong consensus: 3/4 analysts say HOLD"
    }
  ],
  "research_priorities": [
    {
      "priority": "HIGH",
      "focus": "validate_bull_thesis",
      "description": "Strong bullish bias (36 vs 8 signals)",
      "action": "Validate assumptions - could be herd mentality or overlooked risks"
    },
    {
      "priority": "URGENT",
      "focus": "time_sensitive_event",
      "description": "Upcoming catalyst detected",
      "signal": "[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)",
      "source": "fundamental",
      "action": "Research before event occurs"
    }
  ],
  "analyst_reports_summary": {
    "technical": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 3045,
      "has_data": true,
      "completed_successfully": true
    },
    "news": {
      "recommendation": "BUY",
      "confidence": "High",
      "report_length": 5657,
      "has_data": true,
      "completed_successfully": true
    },
    "fundamental": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 3232,
      "has_data": true,
      "completed_successfully": true
    },
    "macro": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 1737,
      "has_data": true,
      "completed_successfully": true
    }
  },
  "data_quality": {
    "status": "COMPLETE",
    "total_analysts": 4,
    "valid_analysts": 4,
    "failed_analysts": 0,
    "failed_list": [],
    "note": null
  },
  "llm_synthesis": "Synthesis error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
  "synthesis_direction": "UNDETERMINED",
  "synthesis_confidence": "N/A"
}